Business Description
Ningbo Menovo Pharmaceutical Co Ltd
ISIN : CNE100002Y25
Share Class Description:
SHSE:603538: Class ACompare
Compare
Traded in other countries / regions
603538.China IPO Date
2017-04-07Description
Ningbo Menovo Pharmaceutical Co Ltd is a China-based company is engaged in the research and development, pilot, production and sales of pharmaceutical intermediates, APIs and finished drugs. Its products line includes cardiovascular, central nervous, respiratory, anti-tumor, anti-infective, digestive system, geriatric diseases and anti-viral systems.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.56 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.65 | |||||
| Debt-to-EBITDA | 22.45 | |||||
| Interest Coverage | 3.13 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.54 | |||||
| Beneish M-Score | -2.73 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3.3 | |||||
| 3-Year EBITDA Growth Rate | -24.1 | |||||
| 3-Year EPS without NRI Growth Rate | -53.1 | |||||
| 3-Year FCF Growth Rate | -28.4 | |||||
| 3-Year Book Growth Rate | 9.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 61.64 | |||||
| 9-Day RSI | 57.38 | |||||
| 14-Day RSI | 57.45 | |||||
| 6-1 Month Momentum % | 1.83 | |||||
| 12-1 Month Momentum % | -37.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.22 | |||||
| Quick Ratio | 0.72 | |||||
| Cash Ratio | 0.49 | |||||
| Days Inventory | 294.97 | |||||
| Days Sales Outstanding | 77.96 | |||||
| Days Payable | 223.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.14 | |||||
| Dividend Payout Ratio | 0.33 | |||||
| 3-Year Dividend Growth Rate | 27.8 | |||||
| Forward Dividend Yield % | 0.14 | |||||
| 5-Year Yield-on-Cost % | 0.14 | |||||
| 3-Year Average Share Buyback Ratio | -0.7 | |||||
| Shareholder Yield % | -3.23 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.44 | |||||
| Operating Margin % | 7.29 | |||||
| Net Margin % | 1.64 | |||||
| FCF Margin % | 5.57 | |||||
| ROE % | 0.96 | |||||
| ROA % | 0.45 | |||||
| ROIC % | 1.82 | |||||
| ROC (Joel Greenblatt) % | 2.98 | |||||
| ROCE % | 2.06 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 230.33 | |||||
| Forward PE Ratio | 9.73 | |||||
| PS Ratio | 2.76 | |||||
| PB Ratio | 1.39 | |||||
| Price-to-Tangible-Book | 1.55 | |||||
| Price-to-Free-Cash-Flow | 86.38 | |||||
| Price-to-Operating-Cash-Flow | 20.16 | |||||
| EV-to-EBIT | 57.71 | |||||
| EV-to-EBITDA | 57.71 | |||||
| EV-to-Revenue | 2.94 | |||||
| EV-to-FCF | 51.87 | |||||
| Earnings Yield (Greenblatt) % | 1.73 | |||||
| FCF Yield % | 2.28 | |||||
| Forward Rate of Return (Yacktman) % | -32.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ningbo Menovo Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,237.044 | ||
| EPS (TTM) (Â¥) | 0.06 | ||
| Beta | 0.34 | ||
| Volatility % | 40.21 | ||
| 14-Day RSI | 57.45 | ||
| 14-Day ATR (Â¥) | 0.463789 | ||
| 20-Day SMA (Â¥) | 13.7355 | ||
| 12-1 Month Momentum % | -37.03 | ||
| 52-Week Range (Â¥) | 9.96 - 21.5 | ||
| Shares Outstanding (Mil) | 218.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ningbo Menovo Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ningbo Menovo Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ningbo Menovo Pharmaceutical Co Ltd Frequently Asked Questions
What is Ningbo Menovo Pharmaceutical Co Ltd(SHSE:603538)'s stock price today?
The current price of SHSE:603538 is ¥13.82. The 52 week high of SHSE:603538 is ¥21.50 and 52 week low is ¥9.96.
When is next earnings date of Ningbo Menovo Pharmaceutical Co Ltd(SHSE:603538)?
The next earnings date of Ningbo Menovo Pharmaceutical Co Ltd(SHSE:603538) is .
Does Ningbo Menovo Pharmaceutical Co Ltd(SHSE:603538) pay dividends? If so, how much?
The Dividend Yield %  of Ningbo Menovo Pharmaceutical Co Ltd(SHSE:603538) is 0.14% (As of Today), Highest Dividend Payout Ratio of Ningbo Menovo Pharmaceutical Co Ltd(SHSE:603538) was 4.13. The lowest was 0.19. And the median was 0.21. The  Forward Dividend Yield % of Ningbo Menovo Pharmaceutical Co Ltd(SHSE:603538) is 0.14%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers